Arizona State Retirement System Anavex Life Sciences Corp. Transaction History

Arizona State Retirement System

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$4.55 - $6.75 $1,592 - $2,362	-350 Reduced 1.53%	22,559 $114,000
Q4 2023 Jan 24, 2024	SELL	$5.04 - $9.95 $544 - $1,074	-108 Reduced 0.47%	22,909 $213,000
Q3 2023 Nov 06, 2023	BUY	$6.55 - $9.37 $4,303 - $6,156	657 Added 2.94%	23,017 $150,000
Q2 2023 Aug 01, 2023	SELL	$7.66 - $9.5 $1,754 - $2,175	-229 Reduced 1.01%	22,360 $181,000
Q1 2023 Apr 27, 2023	BUY	$8.32 - $11.75 $4,958 - $7,003	596 Added 2.71%	22,589 $193,000
Q4 2022 Feb 07, 2023	BUY	$7.65 - $14.43 $7,321 - $13,809	957 Added 4.55%	21,993 $203,000
Q3 2022 Nov 07, 2022	BUY	$8.9 - $12.86 $3,497 - $5,053	393 Added 1.9%	21,036 $217,000
Q2 2022 Jul 28, 2022	BUY	$7.31 - $12.84 $8,201 - $14,406	1,122 Added 5.75%	20,643 $207,000
Q1 2022 May 04, 2022	BUY	$9.74 - $17.69 $1,587 - $2,883	163 Added 0.84%	19,521 $240,000
Q4 2021 Feb 04, 2022	BUY	$16.88 - $23.31 $20,829 - $28,764	1,234 Added 6.81%	19,358 $336,000
Q3 2021 Nov 12, 2021	BUY	$16.82 - $25.75 $672 - $1,030	40 Added 0.22%	18,124 $325,000
Q2 2021 Aug 02, 2021	BUY	$10.16 - $28.86 $183,733 - $521,904	18,084 New	18,084 $413,000

152

26.5M

674K

811K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $443M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.